Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
39%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
XPH
55
HOLDINGS
43%
ALSO IN PJP
PJP
29
HOLDINGS
72%
ALSO IN XPH
SECTOR DRIFT (XPH minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
SUPERNUS PHARMACEUTICALS INC | 2.0% | 2.8% | 2.0% |
|
MERCK & CO. INC. | 2.0% | 5.0% | 2.0% |
|
ELI LILLY & CO | 2.0% | 5.4% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% | 2.5% | 1.9% |
|
LIGAND PHARMACEUTICALS-CL B | 1.9% | 2.9% | 1.9% |
XPH Overweight Relative to PJP
|
NUVATION BIO INC CLASS A | 2.2% |
|
EDGEWISE THERAPEUTICS, INC. | 2.0% |
|
EYEPOINT PHARMACEUTICALS INC | 2.0% |
|
ZOETIS INC | 1.9% |
|
ELANCO ANIMAL HEALTH, INC. | 1.9% |
|
ESPERION THERAPEUTICS INC | 1.9% |
|
LIQUIDIA TECHNOLOGIES, INC. | 1.9% |
|
PHATHOM PHARMACEUTICALS, INC. | 1.9% |
|
ROYALTY PHARMA PLC CLASS A | 1.9% |
|
AXSOME THERAPEUTICS, INC. | 1.9% |
XPH Underweight Relative to PJP
|
ABBVIE INC | -5.3% |
|
AMGEN INC | -4.9% |
|
ABBOTT LABORATORIES | -4.9% |
|
GILEAD SCIENCES INC | -4.7% |
|
UNITED THERAPEUTICS CORP | -3.8% |
|
TRAVERE THERAPEUTICS, INC. | -3.7% |
|
ELI LILLY & CO | -3.4% |
|
PFIZER INC | -3.4% |
|
JOHNSON & JOHNSON | -3.2% |
|
BIOGEN IDEC INC | -3.0% |